In this webinar, Drs. Tappenden and DiBaise will discuss the gut microbiome’s relationship to human health, with an emphasis on methods aimed at modifying the microbial communities in individuals with gut dysbiosis. Specific topics to be addressed include the use of fecal microbiota transplant for treating Clostridium difficile (C. difficile) infections, the potential to apply this treatment to other conditions associated dysbiosis, and the role of pre- and probiotic supplementation in restoring balance of gut dysbiosis. These focus areas build off of the October 2016 webinar, “Microbiome: Research Update and Cutting Edge Applications,” which provided an overview of the gut microbiome and its proposed impact on health and disease.
Describe the essential components of fecal microbiota transplantation (FMT)
Discuss the role of FMT in the eradication of C. difficile infections and explore other potential clinical applications of this treatment
Describe the role of pre- and probiotics in restoring and maintaining healthy microbial communities
Identify appropriate pre- and probiotics sources for use in individuals with dysbiosis
Professor of Medicine,
Division of Gastroenterology and Hepatology, Mayo Clinic in Arizona, Scottsdale, AZ